Literature DB >> 28571199

An Unusual Case of Eosinophilia.

Aashika Sunil Janwadkar1, Jitendra Rajendra Ingole2.   

Abstract

Various inflammatory markers have been used to show an association between welding and respiratory tract disorders due to inhalation of fumes. We hereby present a case of 19-year-old male, welder by occupation who presented with upper respiratory tract infection and was documented to have persistent moderate eosinophilia on serial Complete Blood Count (CBC) examination. This was also confirmed by bone marrow examination which was suggestive of increased eosinophilic precursors. Eosinophils are an inflammatory marker and are increased most commonly in respiratory tract of welders due to inhalation of metal fumes. Treatment with steroid is gratifying and provides short term symptomatic relief. Avoidance of metal fumes and/or change of job is the long term preventive measure. Welding occupation, as a risk factor, should be considered for causation of persistent respiratory tract inflammation with eosinophilia.

Entities:  

Keywords:  Metal fumes; Occupational hazards; Welders

Year:  2017        PMID: 28571199      PMCID: PMC5449845          DOI: 10.7860/JCDR/2017/25654.9747

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

Review 1.  The immunobiology of eosinophils.

Authors:  P F Weller
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

Review 2.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

Review 3.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

4.  Inflammatory responses to the occupational inhalation of metal fume.

Authors:  K T Palmer; R M C McNeill Love; R McNeill-Love; J R Poole; D Coggon; A J Frew; C H Linaker; J K Shute
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.